A Phase 1 interventional study of PF-06882961 and Rosuvastatin in Obesity, sponsored by Pfizer. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-12-01.
Sponsored by Pfizer · Phase 1, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Obesity by Pfizer — 13 open to participants now, 19 under way, 12 of them phase 3. Obesity · Pfizer.
Among the 64 studies in Obesity by Pfizer, this one is the 58th largest by enrollment of the 62 interventional ones that give a count, is one of 3 that started in 2020, is one of 30 in phase 1, and was the 27th registered.
11,543 studies on the registry are indexed under Obesity; 2,047 are open to participants now.
Browse Obesity studies →13 of the 64 studies in Obesity by Pfizer are open now, in 12 countries. Recruiting first, the newest first:
Pfizer · Sites in China
Ages 18+
Pfizer · Sites in United States
Ages 18+
Pfizer · Sites in United States, Canada
Ages 18+
Pfizer · Sites in United States
Ages 18+ · Healthy volunteers
Pfizer · Sites in Japan
Ages 18+
By country, each count listing its studies:
Of the 1,342 Obesity studies recruiting now, 377 (28%) set no upper age limit and 861 (64%) stop at 75 or younger; 168 take children under 18; 489 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 32 · Phase 2 14 · Phase 3 17
First in 2004; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 16 is below the median of 67 across 9,023 interventional studies indexed under Obesity.
Median enrollment 127 across the 62 interventional studies, 53,752 across the 2 observational. Of the 43 that completed or were terminated, 11 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
Pfizer is the lead sponsor of 3,337 studies on the registry; 148 are open to participants now.
Of its 601 completed or terminated interventional studies of FDA-regulated products, 392 (65%) have results posted.
8 of the studies in Obesity by Pfizer that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07311850Phase 3PfizerEfficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity | 2027-09-21 |
| NCT07400653Phase 3PfizerA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) | 2027-10-12 |
| NCT07725809PfizerA Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity | 2027-01-13 |
| NCT07508241PfizerA Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity | 2027-01-27 |
| NCT07845513PfizerA Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity | 2027-02-21 |
Add all 8 to your calendar (.ics) → With an account.
Among the 64 studies in Obesity by Pfizer, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A Phase 1 Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
This study is designed to look at the effect of two doses of PF 06882961 (120 milligram (mg) twice a day (BID) and 200 mg BID) on the levels of one dose of rosuvastatin 10 mg and one dose of midazolam 2 mg, in otherwise healthy, adult participants with obesity. Total duration of study from screening to the telephone visit will be approximately 17 weeks, of which up to 63 days will be inpatient. All subjects take (i) Rosuvastatin alone, Midazolam alone, PF 06882961 alone (120 mg BID), PF 06882961 (120 mg BID) + Rosuvastatin, PF 06882961 (120 mg BID) + Midazolam, PF 06882961 (200 mg BID) alone, PF 06882961 (200 mg BID) + Rosuvastatin, PF 06882961 (200 mg BID)+ Midazolam in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive the following treatments in this sequence : (i)Rosuvastatin alone (one dose of 10 mg), (ii) Midazolam alone (one dose of 2mg), (iii) PF 06882961 alone (120 mg twice daily), (iv) PF 06882961 (120 mg twice daily) + Rosuvastatin (one dose of 10mg), (v) PF 06882961 (120 mg) + Midazolam (one dose of 2 mg), (vi) PF 06882961 (200 mg) alone, (vii) PF 06882961 (200 mg) + Rosuvastatin (one dose of 10 mg), (viii) PF 06882961 (200 mg)+ Midazolam (one dose of 2 mg) in the study.
Drug: PF-06882961 · Drug: Rosuvastatin · Drug: Midazolam
120 mg and 200 mg BID
10 mg single dose
2mg single dose
Area Under the Plasma Concentration-time Profile From Time 0 to Last Quantifiable Concentration (AUClast) of Rosuvastatin in Periods 1, 4 and 7
AUClast is area under the plasma concentration-time profile from time 0 to last quantifiable concentration.
Time frame: At 0 (prior to rosuvastatin dose), 1, 2, 3, 4, 5, 6, 8, 10, 12, 16, 24, 48, and 72 hours post rosuvastatin dose on Day 1 in Periods 1, 4, and 7
AUClast of Midazolam in Periods 2, 5 and 8
AUClast is area under the plasma concentration-time profile from time 0 to last quantifiable concentration.
Time frame: At 0 (prior to midazolam dose), 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 16, and 24 hours post midazolam dose on Day 1 in Periods 2, 5, and 8
Number of Participants With Treatment-emergent Adverse Events (TEAEs)
An adverse event (AE) was any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. A serious adverse event (SAE) was defined as any untoward medical occurrence that, at any dose: resulted in death; was life-threatening; required inpatient hospitalization or prolongation of existing hospitalization; resulted in persistent disability/incapacity; was a congenital anomaly/birth defect; or other serious situations such as important medical events. TEAEs were events between first dose of study drug and up to follow-up visit that were absent before treatment or that worsened after treatment. AEs presented below were TEAEs. The investigator was required to use clinical judgment to assess the potential relationship between investigational product and each AE, to define an treatment-related AE.
Time frame: From first dose of study drug (Day 1) to telephone Follow Up (Days 89-96) (approximately up to 96 days)
Number of Participants With Laboratory Abnormalities (Without Regard to Baseline [BL] Abnormality)
Safety laboratory assessments included clinical chemistry, hematology, urinalysis, and other tests. Abnormality was determined at the investigator's discretion.
Time frame: From BL (Day 1, the last pre-dose measurement in Period 1) to Follow Up visit (Days 68-71) (approximately up to 71 days)
Number of Participants With Vital Signs Data Meeting the Pre-defined Categorical Summarization Criteria
Single, supine vital signs assessments included systolic blood pressure (BP), diastolic BP and pulse rate. Abnormality in vital signs included: pulse rate \<40 beats per minute (bpm) or \>120bpm; supine diastolic BP \<50 millimeter of mercury (mmHg), increase and decrease in change from BL of \>=20mmHg; supine systolic blood pressure \<90mmHg, increase and decrease in change from BL of \>=30mmHg.
Time frame: From BL (Day 1, the last pre-dose measurement in Period 1) to Follow Up visit (Days 68-71) (approximately up to 71 days)
Change From Baseline in Body Weight
Changes from Baseline in body weight of the participants were measured.
Time frame: At BL (Period 1 Day 1), on Period 3 Days 1, 8, 15 and 22, Period 4 Day 1, Period 6 Days 1 and 9, Period 7 Day 1, Period 8 Day 2, and at Follow Up visit (Days 68-71)
Number of Participants With Electrocardiogram (ECG) Data Meeting the Pre-defined Categorical Summarization Criteria
ECG assessments included pulse rate (PR), QT, QTcF intervals and QRS complex. ECG abnormalities criteria included: PR interval value \>= 300msec, or BL \>200msec and \>=25% increase from BL, or BL \<=200msec and \>=50% increase from BL; QRS interval value \>= 140msec, or percent change from BL \>=50%; QTcF value \>400 and \<=480msec, or \>480 and \<=500 msec, or \>500msec, or change from BL\>30 and \<=60msec, or change from BL \>60msec.
Time frame: From BL (Day 1, the last pre-dose measurement in Period 1) to Follow Up visit (Days 68-71) (approximately up to 71 days)
Number of Participants With Positive Response on the Columbia Suicide Severity Rating Scale (C-SSRS)
The C-SSRS was an interview-based rating scale to systematically assess suicidal ideation and suicidal behavior. C-SSRS assessed whether participant experienced any of the following 1: completed suicide, 2: suicide attempt (response of "yes" on "actual attempt"), 3: preparatory acts towards imminent suicidal behavior ("yes" on "aborted attempt", "interrupted attempt", "preparatory acts/behavior"), 4: suicidal ideation ("yes" on "wish to be dead", "non-specific active suicidal thoughts"), 7: self-injurious behavior, no suicidal intent ("yes" on "has participant engaged in non-suicidal self-injurious behavior"). In this outcome, number of participants with positive response (response of "yes") to suicidal behavior, ideation, or any self-injurious behavior were reported.
Time frame: At BL (Period 1 Day 1), on Period 3 Days 1, 8, 15, and 22, Period 4 Day 1, Period 6 Days 1, 9, and 16, Period 8 Day 2, at Follow Up visit (Days 68-71) and Early Termination
Number of Participants With Categorical Scores on the Patient Health Questionnaire (PHQ-9)
The PHQ-9 is a 9 item self-report scale for the assessment of depressive symptoms. The questions included "little interest/pleasure in things", "feeling down depressed or hopeless", "trouble falling or staying asleep", "feeling tired or little energy", "poor appetite or overeating", "feeling bad about yourself", "trouble concentrating on things", "moving slowly or fidgety/restless" and "thoughts you be better off dead". Each item was scored on scale of "not at all", "several days", "more than half the days" to "nearly every day". Total score range: 0-27 (each item with scale from 0 \[not at all\] to 3 \[nearly every day\]. Higher score=greater severity).
Time frame: At BL (Period 1 Day 1), on Period 3 Days 1, 8, 15, and 22, Period 4 Day 1, Period 6 Days 1, 9, and 16, Period 8 Day 2, at Follow Up visit (Days 68-71) and Early Termination
| Milestone | All Participants |
|---|---|
| Started | 16 |
| Completed | 16 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 16 |
| Completed | 16 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 16 |
| Completed | 14 |
| Not completed | 2 |
| Withdrew: Physician decision due to inappropriate behavior and noncompliance | 1 |
| Withdrew: Adverse event | 1 |
| Milestone | All Participants |
|---|---|
| Started | 14 |
| Completed | 14 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 14 |
| Completed | 14 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 14 |
| Completed | 14 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 14 |
| Completed | 14 |
| Not completed | 0 |
| Milestone | All Participants |
|---|---|
| Started | 14 |
| Completed | 13 |
| Not completed | 1 |
| Withdrew: Adverse event | 1 |
AUClast is area under the plasma concentration-time profile from time 0 to last quantifiable concentration.
| nanogram*hour per milliliter (ng*hr/mL) | Rosuvastatin 10mg (Period 1) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) |
|---|---|---|---|
| Area Under the Plasma Concentration-time Profile From Time 0 to Last Quantifiable Concentration (AUClast) of Rosuvastatin in Periods 1, 4 and 7 | 35.17 ± 43 | 72.15 ± 50 | 100.90 ± 40 |
AUClast is area under the plasma concentration-time profile from time 0 to last quantifiable concentration.
| nanogram*hour per milliliter (ng*hr/mL) | Midazolam 2mg (Period 2) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|
| AUClast of Midazolam in Periods 2, 5 and 8 | 39.24 ± 27 | 19.98 ± 49 | 20.21 ± 48 |
An adverse event (AE) was any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. A serious adverse event (SAE) was defined as any untoward medical occurrence that, at any dose: resulted in death; was life-threatening; required inpatient hospitalization or prolongation of existing hospitalization; resulted in persistent disability/incapacity; was a congenital anomaly/birth defect; or other serious situations such as important medical events. TEAEs were events between first dose of study drug and up to follow-up visit that were absent before treatment or that worsened after treatment. AEs presented below were TEAEs. The investigator was required to use clinical judgment to assess the potential relationship between investigational product and each AE, to define an treatment-related AE.
| Participants | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| All-causality TEAEs | 0 | 2 | 13 | 6 | 5 | 11 | 7 | 8 |
| Treatment-related TEAEs | 0 | 0 | 11 | 5 | 5 | 10 | 3 | 7 |
Safety laboratory assessments included clinical chemistry, hematology, urinalysis, and other tests. Abnormality was determined at the investigator's discretion.
| Participants | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| Number of Participants With Laboratory Abnormalities (Without Regard to Baseline [BL] Abnormality) | 0 | 3 | 5 | 2 | 3 | 5 | 0 | 9 |
Single, supine vital signs assessments included systolic blood pressure (BP), diastolic BP and pulse rate. Abnormality in vital signs included: pulse rate \<40 beats per minute (bpm) or \>120bpm; supine diastolic BP \<50 millimeter of mercury (mmHg), increase and decrease in change from BL of \>=20mmHg; supine systolic blood pressure \<90mmHg, increase and decrease in change from BL of \>=30mmHg.
| Participants | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| Pulse rate value <40bpm | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pulse rate value >120bpm | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Supine diastolic BP value <50mmHg | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Supine diastolic BP change >=20mmHg increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Supine diastolic BP change >=20mmHg decrease | 0 | 0 | 1 | 0 | 3 | 3 | 1 | 1 |
| Supine systolic BP value <90mmHg | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| Supine systolic BP change >=30mmHg increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Supine systolic BP change >=30mmHg decrease | 0 | 0 | 2 | 0 | 2 | 3 | 2 | 0 |
Changes from Baseline in body weight of the participants were measured.
| kilogram (kg) | All Participants |
|---|---|
| Period 3 Day 1 / PF-06882961 titration up to 120 mg BID | -1.5 ± 0.82 |
| Period 3 Day 8 / PF-06882961 titration up to 120 mg BID | -1.9 ± 1.56 |
| Period 3 Day 15 / PF-06882961 titration up to 120 mg BID | -3.3 ± 1.24 |
| Period 3 Day 22 / PF-06882961 titration up to 120 mg BID | -4.3 ± 1.69 |
| Period 4 Day 1 / PF-06882961 120 mg BID + rosuvastatin 10 mg | -5.2 ± 1.87 |
| Period 6 Day 1 / PF-06882961 titration up to 200 mg BID | -6.1 ± 2.18 |
| Period 6 Day 9 / PF-06882961 titration up to 200 mg BID | -7.5 ± 2.49 |
| Period 7 Day 1 / PF-06882961 200 mg BID + rosuvastatin 10 mg | -9.1 ± 2.76 |
| Period 8 Day 2 / PF-06882961 200 mg BID + midazolam 2 mg | -9.9 ± 3.15 |
| Follow up | -5.7 ± 3.05 |
ECG assessments included pulse rate (PR), QT, QTcF intervals and QRS complex. ECG abnormalities criteria included: PR interval value \>= 300msec, or BL \>200msec and \>=25% increase from BL, or BL \<=200msec and \>=50% increase from BL; QRS interval value \>= 140msec, or percent change from BL \>=50%; QTcF value \>400 and \<=480msec, or \>480 and \<=500 msec, or \>500msec, or change from BL\>30 and \<=60msec, or change from BL \>60msec.
| Participants | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| PR interval value>=300 msec | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| PR interval %change >=25/50% (BL >200 msec and >=25% increase or BL <=200 msec and >=50% increase) | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| QRS interval value>=140 msec | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QRS interval %change >=50% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QTcF value >450 and <=480 msec | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 0 |
| QTcF value >480 and <=500 msec | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QTcF value >500 msec | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QTcF change >30 and <=60 msec | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QTcF change >60 msec | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
The C-SSRS was an interview-based rating scale to systematically assess suicidal ideation and suicidal behavior. C-SSRS assessed whether participant experienced any of the following 1: completed suicide, 2: suicide attempt (response of "yes" on "actual attempt"), 3: preparatory acts towards imminent suicidal behavior ("yes" on "aborted attempt", "interrupted attempt", "preparatory acts/behavior"), 4: suicidal ideation ("yes" on "wish to be dead", "non-specific active suicidal thoughts"), 7: self-injurious behavior, no suicidal intent ("yes" on "has participant engaged in non-suicidal self-injurious behavior"). In this outcome, number of participants with positive response (response of "yes") to suicidal behavior, ideation, or any self-injurious behavior were reported.
| Participants | All Participants |
|---|---|
| BL | 0 |
| BL (Past 12 months) | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID (Since last visit) | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID (Since last visit) | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID (Since last visit) | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID (Since last visit) | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg (Since last visit) | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID (Since last visit) | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID (Since last visit) | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID (Since last visit) | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg (Since last visit) | 0 |
| Follow Up (Since last visit) | 0 |
| Early Termination (ET) (Since last visit) | 0 |
The PHQ-9 is a 9 item self-report scale for the assessment of depressive symptoms. The questions included "little interest/pleasure in things", "feeling down depressed or hopeless", "trouble falling or staying asleep", "feeling tired or little energy", "poor appetite or overeating", "feeling bad about yourself", "trouble concentrating on things", "moving slowly or fidgety/restless" and "thoughts you be better off dead". Each item was scored on scale of "not at all", "several days", "more than half the days" to "nearly every day". Total score range: 0-27 (each item with scale from 0 \[not at all\] to 3 \[nearly every day\]. Higher score=greater severity).
| Participants | All Participants |
|---|---|
| BL Little Interest/Pleasure in Things — Not At All | 16 |
| BL Little Interest/Pleasure in Things — Several Days | 0 |
| BL Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| BL Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| BL Feeling Down Depressed or Hopeless — Not At All | 16 |
| BL Feeling Down Depressed or Hopeless — Several Days | 0 |
| BL Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| BL Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| BL Trouble Falling or Staying Asleep — Not At All | 16 |
| BL Trouble Falling or Staying Asleep — Several Days | 0 |
| BL Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| BL Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| BL Feeling Tired or Little Energy — Not At All | 16 |
| BL Feeling Tired or Little Energy — Several Days | 0 |
| BL Feeling Tired or Little Energy — More Than Half The Days | 0 |
| BL Feeling Tired or Little Energy — Nearly Every Day | 0 |
| BL Poor Appetite or Overeating — Not At All | 15 |
| BL Poor Appetite or Overeating — Several Days | 1 |
| BL Poor Appetite or Overeating — More Than Half The Days | 0 |
| BL Poor Appetite or Overeating — Nearly Every Day | 0 |
| BL Feeling Bad About Yourself — Not At All | 16 |
| BL Feeling Bad About Yourself — Several Days | 0 |
| BL Feeling Bad About Yourself — More Than Half The Days | 0 |
| BL Feeling Bad About Yourself — Nearly Every Day | 0 |
| BL Trouble Concentrating on Things — Not At All | 16 |
| BL Trouble Concentrating on Things — Several Days | 0 |
| BL Trouble Concentrating on Things — More Than Half The Days | 0 |
| BL Trouble Concentrating on Things — Nearly Every Day | 0 |
| BL Moving Slowly or Fidgety/Restless — Not At All | 16 |
| BL Moving Slowly or Fidgety/Restless — Several Days | 0 |
| BL Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| BL Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| BL Thoughts You Be Better Off Dead — Not At All | 16 |
| BL Thoughts You Be Better Off Dead — Several Days | 0 |
| BL Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| BL Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 3 Day 1/PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Not At All | 16 |
| Period 3 Day 1/PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 3 Day 1/PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 3 Day 1/PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Not At All | 15 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Several Days | 1 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Not At All | 16 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 3 Day 1 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Several Days | 1 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Not At All | 14 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Several Days | 1 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Not At All | 15 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 3 Day 8 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Not At All | 14 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Several Days | 1 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Not At All | 15 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Several Days | 1 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Not At All | 14 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Several Days | 1 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Not At All | 13 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Several Days | 2 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Not At All | 15 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Not At All | 15 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Not At All | 15 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Not At All | 15 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 3 Day 15 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Not At All | 13 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Several Days | 1 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Not At All | 11 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Several Days | 3 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 3 Day 22 / PF-06882961 titration up to 120mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Little Interest/Pleasure in Things — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Little Interest/Pleasure in Things — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Down Depressed or Hopeless — Not At All | 13 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Down Depressed or Hopeless — Several Days | 1 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Tired or Little Energy — Not At All | 11 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Tired or Little Energy — Several Days | 3 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Poor Appetite or Overeating — Not At All | 12 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Poor Appetite or Overeating — Several Days | 2 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Bad About Yourself — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Bad About Yourself — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Concentrating on Things — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Concentrating on Things — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 4 Day 1 / PF-06882961 120mg BID + rosuvastatin 10mg Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Not At All | 14 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Not At All | 14 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Not At All | 12 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Several Days | 2 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Not At All | 13 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Several Days | 1 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Not At All | 11 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Several Days | 3 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Not At All | 14 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Not At All | 13 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Several Days | 1 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 6 Day 1 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Not At All | 13 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Several Days | 1 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Not At All | 12 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Several Days | 2 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 6 Day 9 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Not At All | 11 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Several Days | 3 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Not At All | 13 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Several Days | 1 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 6 Day 16 / PF-06882961 titration up to 200mg BID Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Little Interest/Pleasure in Things — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Little Interest/Pleasure in Things — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Down Depressed or Hopeless — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Down Depressed or Hopeless — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Falling or Staying Asleep — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Falling or Staying Asleep — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Tired or Little Energy — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Tired or Little Energy — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Poor Appetite or Overeating — Not At All | 12 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Poor Appetite or Overeating — Several Days | 1 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Poor Appetite or Overeating — More Than Half The Days | 1 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Poor Appetite or Overeating — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Bad About Yourself — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Bad About Yourself — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Bad About Yourself — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Feeling Bad About Yourself — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Concentrating on Things — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Concentrating on Things — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Concentrating on Things — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Trouble Concentrating on Things — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Moving Slowly or Fidgety/Restless — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Thoughts You Be Better Off Dead — Not At All | 14 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Thoughts You Be Better Off Dead — Several Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Period 8 Day 2 / PF-06882961 200mg BID + midazolam 2mg Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| Follow Up Little Interest/Pleasure in Things — Not At All | 15 |
| Follow Up Little Interest/Pleasure in Things — Several Days | 0 |
| Follow Up Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| Follow Up Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| Follow Up Feeling Down Depressed or Hopeless — Not At All | 15 |
| Follow Up Feeling Down Depressed or Hopeless — Several Days | 0 |
| Follow Up Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| Follow Up Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| Follow Up Trouble Falling or Staying Asleep — Not At All | 15 |
| Follow Up Trouble Falling or Staying Asleep — Several Days | 0 |
| Follow Up Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| Follow Up Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| Follow Up Feeling Tired or Little Energy — Not At All | 15 |
| Follow Up Feeling Tired or Little Energy — Several Days | 0 |
| Follow Up Feeling Tired or Little Energy — More Than Half The Days | 0 |
| Follow Up Feeling Tired or Little Energy — Nearly Every Day | 0 |
| Follow Up Poor Appetite or Overeating — Not At All | 15 |
| Follow Up Poor Appetite or Overeating — Several Days | 0 |
| Follow Up Poor Appetite or Overeating — More Than Half The Days | 0 |
| Follow Up Poor Appetite or Overeating — Nearly Every Day | 0 |
| Follow Up Feeling Bad About Yourself — Not At All | 15 |
| Follow Up Feeling Bad About Yourself — Several Days | 0 |
| Follow Up Feeling Bad About Yourself — More Than Half The Days | 0 |
| Follow Up Feeling Bad About Yourself — Nearly Every Day | 0 |
| Follow Up Trouble Concentrating on Things — Not At All | 15 |
| Follow Up Trouble Concentrating on Things — Several Days | 0 |
| Follow Up Trouble Concentrating on Things — More Than Half The Days | 0 |
| Follow Up Trouble Concentrating on Things — Nearly Every Day | 0 |
| Follow Up Moving Slowly or Fidgety/Restless — Not At All | 15 |
| Follow Up Moving Slowly or Fidgety/Restless — Several Days | 0 |
| Follow Up Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| Follow Up Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| Follow Up Thoughts You Be Better Off Dead — Not At All | 15 |
| Follow Up Thoughts You Be Better Off Dead — Several Days | 0 |
| Follow Up Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| Follow Up Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
| ET Little Interest/Pleasure in Things — Not At All | 1 |
| ET Little Interest/Pleasure in Things — Several Days | 0 |
| ET Little Interest/Pleasure in Things — More Than Half The Days | 0 |
| ET Little Interest/Pleasure in Things — Nearly Every Day | 0 |
| ET Feeling Down Depressed or Hopeless — Not At All | 1 |
| ET Feeling Down Depressed or Hopeless — Several Days | 0 |
| ET Feeling Down Depressed or Hopeless — More Than Half The Days | 0 |
| ET Feeling Down Depressed or Hopeless — Nearly Every Day | 0 |
| ET Trouble Falling or Staying Asleep — Not At All | 1 |
| ET Trouble Falling or Staying Asleep — Several Days | 0 |
| ET Trouble Falling or Staying Asleep — More Than Half The Days | 0 |
| ET Trouble Falling or Staying Asleep — Nearly Every Day | 0 |
| ET Feeling Tired or Little Energy — Not At All | 1 |
| ET Feeling Tired or Little Energy — Several Days | 0 |
| ET Feeling Tired or Little Energy — More Than Half The Days | 0 |
| ET Feeling Tired or Little Energy — Nearly Every Day | 0 |
| ET Poor Appetite or Overeating — Not At All | 1 |
| ET Poor Appetite or Overeating — Several Days | 0 |
| ET Poor Appetite or Overeating — More Than Half The Days | 0 |
| ET Poor Appetite or Overeating — Nearly Every Day | 0 |
| ET Feeling Bad About Yourself — Not At All | 1 |
| ET Feeling Bad About Yourself — Several Days | 0 |
| ET Feeling Bad About Yourself — More Than Half The Days | 0 |
| ET Feeling Bad About Yourself — Nearly Every Day | 0 |
| ET Trouble Concentrating on Things — Not At All | 1 |
| ET Trouble Concentrating on Things — Several Days | 0 |
| ET Trouble Concentrating on Things — More Than Half The Days | 0 |
| ET Trouble Concentrating on Things — Nearly Every Day | 0 |
| ET Moving Slowly or Fidgety/Restless — Not At All | 1 |
| ET Moving Slowly or Fidgety/Restless — Several Days | 0 |
| ET Moving Slowly or Fidgety/Restless — More Than Half The Days | 0 |
| ET Moving Slowly or Fidgety/Restless — Nearly Every Day | 0 |
| ET Thoughts You Be Better Off Dead — Not At All | 1 |
| ET Thoughts You Be Better Off Dead — Several Days | 0 |
| ET Thoughts You Be Better Off Dead — More Than Half The Days | 0 |
| ET Thoughts You Be Better Off Dead — Nearly Every Day | 0 |
Collected over From first dose of study drug (Day 1) to telephone Follow Up (Days 89-96) (approximately up to 96 days). Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Rosuvastatin 10mg (Period 1) | 0/16 (0%) | 0/16 (0%) | 0/16 (0%) |
| Midazolam 2mg (Period 2) | 0/16 (0%) | 0/16 (0%) | 2/16 (12.5%) |
| PF-06882961 Titration up to 120mg BID (Period 3) | 0/16 (0%) | 0/16 (0%) | 13/16 (81.3%) |
| PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | 0/14 (0%) | 0/14 (0%) | 6/14 (42.9%) |
| PF-06882961 120mg BID + Midazolam 2mg (Period 5) | 0/14 (0%) | 0/14 (0%) | 5/14 (35.7%) |
| PF-06882961 Titration up to 200mg BID (Period 6) | 0/14 (0%) | 0/14 (0%) | 11/14 (78.6%) |
| PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | 0/14 (0%) | 0/14 (0%) | 7/14 (50%) |
| PF-06882961 200mg BID + Midazolam 2mg (Period 8) | 0/14 (0%) | 1/14 (7.1%) | 8/14 (57.1%) |
| Event | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| Transaminases increasedInvestigations | 0/16 | 0/16 | 0/16 | 0/14 | 0/14 | 0/14 | 0/14 | 1/14 |
| Event | Rosuvastatin 10mg (Period 1) | Midazolam 2mg (Period 2) | PF-06882961 Titration up to 120mg BID (Period 3) | PF-06882961 120mg BID + Rosuvastatin 10mg (Period 4) | PF-06882961 120mg BID + Midazolam 2mg (Period 5) | PF-06882961 Titration up to 200mg BID (Period 6) | PF-06882961 200mg BID + Rosuvastatin 10mg (Period 7) | PF-06882961 200mg BID + Midazolam 2mg (Period 8) |
|---|---|---|---|---|---|---|---|---|
| ConstipationGastrointestinal disorders | 0/16 | 0/16 | 10/16 | 0/14 | 0/14 | 1/14 | 1/14 | 0/14 |
| NauseaGastrointestinal disorders | 0/16 | 0/16 | 8/16 | 5/14 | 0/14 | 4/14 | 1/14 | 0/14 |
| HeadacheNervous system disorders | 0/16 | 0/16 | 6/16 | 0/14 | 0/14 | 1/14 | 2/14 | 0/14 |
| Glomerular filtration rate decreasedInvestigations | 0/16 | 0/16 | 1/16 | 0/14 | 3/14 | 3/14 | 0/14 | 5/14 |
| Early satietyGeneral disorders | 0/16 | 0/16 | 5/16 | 0/14 | 0/14 | 0/14 | 0/14 | 0/14 |
| DyspepsiaGastrointestinal disorders | 0/16 | 0/16 | 4/16 | 0/14 | 0/14 | 1/14 | 1/14 | 0/14 |
| VomitingGastrointestinal disorders | 0/16 | 0/16 | 3/16 | 1/14 | 0/14 | 3/14 | 1/14 | 1/14 |
| Abdominal distensionGastrointestinal disorders | 0/16 | 0/16 | 3/16 | 0/14 | 0/14 | 0/14 | 0/14 | 0/14 |
| FatigueGeneral disorders | 0/16 | 0/16 | 0/16 | 0/14 | 0/14 | 2/14 | 0/14 | 1/14 |
| SomnolenceNervous system disorders | 0/16 | 2/16 | 0/16 | 0/14 | 0/14 | 0/14 | 0/14 | 0/14 |
All enrolled participants who received at least 1 dose of study intervention
| Age, Continuous(Years) | All Participants |
|---|---|
| Mean | 49.0 ± 11.34 |
| Age, Customized(Participants) | All Participants |
|---|---|
| <18 Years | 0 |
| 18-44 Years | 5 |
| 45-65 Years | 11 |
| Sex: Female, Male(Participants) | All Participants |
|---|---|
| Female | 8 |
| Male | 8 |
| Race/Ethnicity, Customized(Participants) | All Participants |
|---|---|
| White | 12 |
| Black or African American | 3 |
| American Indian or Alaska Native | 1 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
Ran from Dec 2020 to primary completion in May 2021, 4 months.
Results were first posted in Dec 2023, 2 years 6 months after primary completion.
Of 335 industry-sponsored phase 1 interventional studies under Obesity, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 15. This study's 4 months is below that.
Counting every sponsor, half of 440 studies reached it within 11 months; a quarter within 6 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Danuglipron